Consumer Health in Norway

CONSUMER HEALTH IN NORWAY

October 2017

List of Contents and Tables

Executive Summary
Consumer Health Sales Develop in Line With Population Growth
2017 Growth in Line With the Review Period
Healthy Balance Between Domestic and Foreign Players
Growing Internet Sales Offer Convenience But Pose A Threat To Unwary Customers
Future Sales of Consumer Health in Line With Population Growth
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 2 Life Expectancy at Birth 2012-2017
Market Data
Table 3 Sales of Consumer Health by Category: Value 2012-2017
Table 4 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 5 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 6 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 8 Distribution of Consumer Health by Format: % Value 2012-2017
Table 9 Distribution of Consumer Health by Format and Category: % Value 2017
Table 10 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches 2016-2017
Sources
Summary 2 Research Sources
Headlines
Prospects
the Ageing Population and Prevalence of Chronic Pain at Older Ages Boosts Sales of Adult Analgesics
Growth of Analgesics Depends on Future Regulations
Sales of Analgesics Will Grow Faster Outside of Chemists/pharmacists
Competitive Landscape
Weifa Remains the Clear Leader
Private Label and Generics Suffer
Weifa, Leader in Innovation, Launches A New Product Which Is Absorbed Faster
Category Data
Table 12 Sales of Analgesics by Category: Value 2012-2017
Table 13 Sales of Analgesics by Category: % Value Growth 2012-2017
Table 14 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
Table 15 NBO Company Shares of Analgesics: % Value 2013-2017
Table 16 LBN Brand Shares of Analgesics: % Value 2014-2017
Table 17 Forecast Sales of Analgesics by Category: Value 2017-2022
Table 18 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
Headlines
Prospects
Extensive Use of Electronic Media One of the Key Drivers of Sleep Aids
Alternatives To Drugs May Limit Future Growth of Sleep Aids
Alternative Therapies May Be More Effective
Competitive Landscape
Sleep Aids Is Controlled by Two Players
Sales of Generics and Private Label Non-existent
Image Remains the Key Factor, But No Noticeable Product and Packaging Innovation Is Seen
Category Data
Table 19 Sales of Sleep Aids: Value 2012-2017
Table 20 Sales of Sleep Aids: % Value Growth 2012-2017
Table 21 NBO Company Shares of Sleep Aids: % Value 2013-2017
Table 22 LBN Brand Shares of Sleep Aids: % Value 2014-2017
Table 23 Forecast Sales of Sleep Aids: Value 2017-2022
Table 24 Forecast Sales of Sleep Aids: % Value Growth 2017-2022
Headlines
Prospects
An Increasing Number of Norwegians Suffer From Allergies, Boosting Category Sales
Nasal Sprays Set To Record the Strongest Growth Over the Forecast Period
Competitive Landscape
Gsk Consumer Healthcare and Cloetta Norge Continue To Lead
Sales of Private Label Products Remain Negligible
Products Widely Available Outside Pharmacies Are Actively Marketed on TV and the Internet
Category Data
Table 25 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
Table 26 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
Table 27 Sales of Decongestants by Category: Value 2012-2017
Table 28 Sales of Decongestants by Category: % Value Growth 2012-2017
Table 29 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2013-2017
Table 30 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2017
Table 31 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
Headlines
Prospects
Pollution and Global Warming To Create Increased Demand for Topical Allergy Remedies/antihistamines
Topical Antifungals and Topical Germicidals/antiseptics Will Also Benefit
Increasing Number of Births To Lead To Increasing Sales of Nappy (diaper) Rash Treatments
Competitive Landscape
Sales Controlled by Giants
Cheaper Private Label and Generic Options Are Non-existent
Canesten Is Further Developed, While Access To the Product Becomes Easier
Category Data
Table 33 Sales of Dermatologicals by Category: Value 2012-2017
Table 34 Sales of Dermatologicals by Category: % Value Growth 2012-2017
Table 35 NBO Company Shares of Dermatologicals: % Value 2013-2017
Table 36 LBN Brand Shares of Dermatologicals: % Value 2014-2017
Table 37 LBN Brand Shares of Hair Loss Treatments: % Value 2014-2017
Table 38 Forecast Sales of Dermatologicals by Category: Value 2017-2022
Table 39 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022
Headlines
Prospects
Consumption of Healthier Food To Limit Digestive Remedies
Physical Activity on the Rise
Less Active, Ageing Consumers To Boost Sales of Laxatives and Antiflatulents
Competitive Landscape
Medically Savvy and Image-orientated Norwegians Refrain From Private Label
Ratiopharm Re-enters Digestive Remedies
Some Medicines From Abroad Can Be Offered by Norwegian Pharmacies
Category Data
Table 40 Sales of Digestive Remedies by Category: Value 2012-2017
Table 41 Sales of Digestive Remedies by Category: % Value Growth 2012-2017
Table 42 NBO Company Shares of Digestive Remedies: % Value 2013-2017
Table 43 LBN Brand Shares of Digestive Remedies: % Value 2014-2017
Table 44 Forecast Sales of Digestive Remedies by Category: Value 2017-2022
Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2017-2022
Headlines
Prospects
Standard Eye Care To Drive Growth Over the Forecast Period
No Breakthrough Is Expected in Sales of Allergy Eye Care
Competitive Landscape
Théa Nordic Remains the Leader
Sales of Private Label Are Non-existent
Eye Care Witnesses A Limited Number of Innovations Due To the Category's Low Sales
Category Data
Table 46 Sales of Eye Care by Category: Value 2012-2017
Table 47 Sales of Eye Care by Category: % Value Growth 2012-2017
Table 48 Sales of Standard Eye Care by Format: % Value 2012-2017
Table 49 Sales of Standard Eye Care by Positioning: % Value 2012-2017
Table 50 NBO Company Shares of Eye Care: % Value 2013-2017
Table 51 LBN Brand Shares of Eye Care: % Value 2014-2017
Table 52 Forecast Sales of Eye Care by Category: Value 2017-2022
Table 53 Forecast Sales of Eye Care by Category: % Value Growth 2017-2022
Headlines
Prospects
Decline in Smoking Prevalence Supports Sales of Nrt Smoking Cessation Aids
Impact of Vapour Devices on Nrt Smoking Cessation
Swedish-style Snus Also An Alternative
Competitive Landscape
Global Giants Lead, However Are Less Active in New Product Launches
Little Room for Private Label and Generics
Swedish Niconovum Highly Active in New Product Launches
Category Indicators
Table 54 Number of Smokers by Gender 2012-2017
Category Data
Table 55 Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
Table 56 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
Table 57 Sales of NRT Gum by Flavour: % Value 2012-2017
Table 58 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2013-2017
Table 59 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2014-2017
Table 60 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
Table 61 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
Headlines
Prospects
Childbirth Trends To Contribute To Growing Sales of Sticking Plasters/adhesive Bandages
Future Growth Depends on Trends Among Children
Future Sales of Wound Care Set To Remain in Line With Population Growth
Competitive Landscape
A Local Player Continues To Lead
Private Label Is Also Present, Unlike in Most OTC Categories
Limited Product Innovation, With Focus on Cartoon Figures and Expanded Sales Channels
Category Data
Table 62 Sales of Wound Care by Category: Value 2012-2017
Table 63 Sales of Wound Care by Category: % Value Growth 2012-2017
Table 64 NBO Company Shares of Wound Care: % Value 2013-2017
Table 65 LBN Brand Shares of Wound Care: % Value 2014-2017
Table 66 Forecast Sales of Wound Care by Category: Value 2017-2022
Table 67 Forecast Sales of Wound Care by Category: % Value Growth 2017-2022
Headlines
Prospects
Sports Nutrition To Become A Mainstream Product Reaching Maturity
Sports Nutrition Joins the Mainstream Channels
Slower Growth Will Call for New Product Formats and Categories With Higher Margins
Competitive Landscape
Proteinfabrikken Leads Sports Nutrition
Gymgrossisten A Close Second
Players Target A Broad Range of Consumer Groups As Sports Nutrition Nears Maturity
Category Data
Table 68 Sales of Sports Nutrition by Category: Value 2012-2017
Table 69 Sales of Sports Nutrition by Category: % Value Growth 2012-2017
Table 70 NBO Company Shares of Sports Nutrition: % Value 2013-2017
Table 71 LBN Brand Shares of Sports Nutrition: % Value 2014-2017
Table 72 Forecast Sales of Sports Nutrition by Category: Value 2017-2022
Table 73 Forecast Sales of Sports Nutrition by Category: % Value Growth 2017-2022
Headlines
Prospects
Pros and Cons of Dietary Supplements Discussed, While Population Growth Will Mitigate Declines
Fish Oils/omega Fatty Acids and Mineral Supplements To Support Sales of Dietary Supplements Over the Forecast Period
Tonics and Minerals To Record the Strongest Growth
Competitive Landscape
Domestic Player Orkla Care Continues To Lead Dietary Supplements
Private Label Is Available
Low Permitted Values for Dietary Supplements in Norway Limits Imports and Sales
Category Data
Summary 3 Dietary Supplements: Brand Ranking by Positioning 2017
Table 74 Sales of Dietary Supplements by Category: Value 2012-2017
Table 75 Sales of Dietary Supplements by Category: % Value Growth 2012-2017
Table 76 Sales of Dietary Supplements by Positioning: % Value 2012-2017
Table 77 Sales of Fish Oils/Omega Fatty Acids by Type: % Value 2012-2017
Table 78 NBO Company Shares of Dietary Supplements: % Value 2013-2017
Table 79 LBN Brand Shares of Dietary Supplements: % Value 2014-2017
Table 80 Forecast Sales of Dietary Supplements by Category: Value 2017-2022
Table 81 Forecast Sales of Dietary Supplements by Category: % Value Growth 2017-2022
Headlines
Prospects
the Growing Number of Vegetarians in Norway Is Set To Contribute To Increasing Sales of Vitamins
Lack of Sunlight A Key Driver of Sales of Vitamin D
Competitive Landscape
Takeda Nycomed Leads Vitamins
Domestic Player in Second Place
Competitive Landscape in Vitamins Differs From That Witnessed in OTC Medicines
Category Data
Summary 4 Multivitamins: Brand Ranking by Positioning 2017
Table 82 Sales of Vitamins by Category: Value 2012-2017
Table 83 Sales of Vitamins by Category: % Value Growth 2012-2017
Table 84 Sales of Multivitamins by Positioning: % Value 2012-2017
Table 85 NBO Company Shares of Vitamins: % Value 2013-2017
Table 86 LBN Brand Shares of Vitamins: % Value 2014-2017
Table 87 Forecast Sales of Vitamins by Category: Value 2017-2022
Table 88 Forecast Sales of Vitamins by Category: % Value Growth 2017-2022
Headlines
Prospects
Static Obesity Rates and Alternative Diets To Contribute To Declining Sales of Weight Management and Wellbeing
Technical Solutions Outperform Sales of Weight Management and Wellbeing
Norwegians Opt To Give Up Bad Habits Instead of Counterbalancing Them by Extensive Use of Weight Management and Wellbeing Products
Competitive Landscape
Domestic Player Remains the Leader
International Players Have A Strong Presence
Internet Retailing To Grow Well Towards the End of the Forecast Period
Category Data
Table 89 Sales of Weight Management and Wellbeing by Category: Value 2012-2017
Table 90 Sales of Weight Management and Wellbeing by Category: % Value Growth 2012-2017
Table 91 NBO Company Shares of Weight Management and Wellbeing: % Value 2013-2017
Table 92 LBN Brand Shares of Weight Management and Wellbeing: % Value 2014-2017
Table 93 Forecast Sales of Weight Management and Wellbeing by Category: Value 2017-2022
Table 94 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2017-2022
Headlines
Prospects
Herbal/traditional Products Reaches Maturity
Prevalence of Insomnia and Changing Regulations Trigger Growth of Herbal/traditional Sleep Aids
Competitive Landscape
Cloetta Norge Remains the Leader With Its Well-established Läkerol Brand
Private Label Is Available
Herbal/traditional Products Lacks Innovation As the Category Is Not Expecting Growth
Category Data
Table 95 Sales of Herbal/Traditional Products by Category: Value 2012-2017
Table 96 Sales of Herbal/Traditional Products by Category: % Value Growth 2012-2017
Table 97 NBO Company Shares of Herbal/Traditional Products: % Value 2013-2017
Table 98 LBN Brand Shares of Herbal/Traditional Products: % Value 2014-2017
Table 99 Forecast Sales of Herbal/Traditional Products by Category: Value 2017-2022
Table 100 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2017-2022
Headlines
Prospects
Slow Growth in the Children's Population and Parents' Care for Them Set To Contribute To Stable Demand for Paediatric Consumer Health
Eea Plans To Implement EU Regulations on Medicine for Children
Competitive Landscape
Norwegian Players Control Paediatric Consumer Health
No Room for Private Label
Medicines for Children Occupy Major Shelf Space in Norway
Category Data
Table 101 Sales of Paediatric Consumer Health by Category: Value 2012-2017
Table 102 Sales of Paediatric Consumer Health by Category: % Value Growth 2012-2017
Table 103 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2014-2017
Table 104 NBO Company Shares of Paediatric Consumer Health: % Value 2013-2017
Table 105 LBN Brand Shares of Paediatric Consumer Health: % Value 2014-2017
Table 106 Forecast Sales of Paediatric Consumer Health by Category: Value 2017-2022
Table 107 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022